Chou and his team were the first to assess the intronic SNP as a risk factor for IGE; according to previous literature, the AA genotype was used as a reference, and they could not find any association between the GABRG2_3145G>A polymorphism and the risk of IGE [14]. This evidence concerns the gene GABRG2 and idiopathic generalized epilepsy.